• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

130.92 +2.34 (+1.82%)
Official Closing Price Updated: 4:10 PM EDT, Aug 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stay informed with the top movers within the dow jones index on Monday. ↗
Today 15:10 EDT
Via Chartmill
These dow jones stocks are moving in today's session ↗
Today 12:40 EDT
Via Chartmill
Which dow jones stocks are moving on Thursday? ↗
August 06, 2026
Via Chartmill
Thursday's session: top gainers and losers in the dow jones index ↗
August 06, 2026
Via Chartmill
Merck (NYSE:MRK) Q2 Loss Narrows, Lifts Full-Year Sales Guidance ↗
August 04, 2026
Via Chartmill
News headline image
U.S. FDA Accepts sBLA for ENFLONSIA™ (clesrovimab-cfor) to Update its Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease Indication to Include Children Under Two Years at Increased Risk for Severe RSV for Their Second Season
August 06, 2026
From Merck & Co., Inc.
Via Business Wire
Uncover the latest developments among dow jones stocks in today's session. ↗
August 05, 2026
Via Chartmill
News headline image
Merck & Co., Inc. Q2 Earnings Call Highlights ↗
August 05, 2026
Merck & Co., Inc. (NYSE:MRK) reported second-quarter revenue of $16.6 billion, up 5% from a year earlier, driven by oncology, animal health and contributions from newer product launches. Revenue... 
Via MarketBeat
Topics Earnings
S&P 500 Prints Fresh Record As Chips Rip And Hormuz Talks Crack The Oil Trade ↗
August 05, 2026
Via Chartmill
Topics Stocks
News headline image
MRK Q2 Deep Dive: Oncology and New Launches Drive Growth Amid Margin Compression
August 05, 2026
Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.1% year on year to $16.61 billion. The c... 
Via StockStory
Which dow jones stocks are moving on Tuesday? ↗
August 04, 2026
Via Chartmill
News headline image
Merck (NYSE:MRK) Posts Better-Than-Expected Sales In Q2 CY2026
August 04, 2026
Global pharmaceutical company Merck (NYSE:MRK) announced better-than-expected revenue in Q2 CY2026, with sales up 5.1% year on year to $16.61 billion. The co... 
Via StockStory
News headline image
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
August 04, 2026
From Merck & Co., Inc.
Via Business Wire
Explore the top gainers and losers within the dow jones index in today's session. ↗
August 03, 2026
Via Chartmill
News headline image
Merck Spotlights Weekly HIV Treatment, Monthly PrEP as $5B Growth Opportunity ↗
August 03, 2026
Merck & Co., Inc. (NYSE:MRK) outlined its HIV treatment and prevention strategy at an investor event following the International AIDS Conference, highlighting Phase III results for a once-weekly oral... 
Via MarketBeat
Top dow jones movers in Monday's session ↗
August 03, 2026
Via Chartmill
News headline image
What To Expect From Merck’s (MRK) Q2 Earnings
August 02, 2026
Global pharmaceutical company Merck (NYSE:MRK) will be announcing earnings results this Tuesday before market hours. Here’s what investors should know. Merck... 
Via StockStory
Top dow jones movers in Friday's session ↗
July 31, 2026
Via Chartmill
News headline image
1 Cash-Producing Stock with Promising Prospects and 2 That Underwhelm
July 31, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
Wednesday's session: top gainers and losers in the dow jones index ↗
July 29, 2026
Via Chartmill
News headline image
Merck Announces Fourth-Quarter 2026 Dividend
July 29, 2026
From Merck & Co., Inc.
Via Business Wire
Uncover the latest developments among dow jones stocks in today's session. ↗
July 28, 2026
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
July 28, 2026
Via Chartmill
Monday's session: top gainers and losers in the dow jones index ↗
July 27, 2026
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
July 24, 2026
Via Chartmill
News headline image
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
July 24, 2026
From Merck & Co., Inc.
Via Business Wire
News headline image
2 Top Growth Stocks to Buy Right Now Without Any Hesitation ↗
July 24, 2026
There are plenty of reasons to love these companies. 
Via The Motley Fool
News headline image
Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer ↗
July 23, 2026
Income seekers shouldn't give up on the stock yet. 
Via The Motley Fool
These dow jones stocks are moving in today's session ↗
July 23, 2026
Via Chartmill
What's going on in today's session: dow jones movers ↗
July 23, 2026
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap